Belgian Universities Lose Epilepsy Drug Patent On Appeal
Two Belgian universities have lost a patent for a drug used to treat a rare and fatal epilepsy syndrome, after European officials ruled that there was no evidence to back up...To view the full article, register now.
Already a subscriber? Click here to view full article